Business Context and Reporting Period
Universal Health Services, Inc. (UHS) filed a Form 8-K on July 20, 2026, reporting the entry into a material definitive agreement. The filing details a Twelfth Amendment to the Company's existing Senior Secured Credit Facility, effective as of July 20, 2026.
Key Financial Metrics and Debt Structure
The filing focuses on debt capacity and liquidity rather than operating performance metrics such as revenue or profit, which are not disclosed in this document.
- New Debt Capacity: Added a new incremental delayed draw tranche A term loan facility of up to $700 million.
- Draw Period: Available for drawdown from July 20, 2026, through September 30, 2026.
- Maturity: The new term loan matures 364 days after the funding date.
- Amortization: The facility does not amortize; full repayment is required on the Maturity Date.
- Interest Margins: Initial margins are 0.125% for ABR Loans and 1.125% for Term Benchmark and RFR Loans, subject to the Company's Consolidated Net Leverage Ratio.
- Existing Debt: The new facility is secured on an equal ratable basis with existing Senior Secured Notes due in 2026, 2029, 2030, 2032, and 2034.
Material Changes Versus Prior Period
The primary material change is the expansion of the Senior Secured Credit Facility to include the $700 million delayed draw term loan. This amendment increases the Company's available liquidity options compared to the prior state of the Credit Agreement.
Guidance, Outlook, and Management Commentary
Use of Proceeds: If drawn, the Company intends to use proceeds for general corporate purposes, including refinancing existing indebtedness and paying associated fees and expenses.
Prepayment Conditions: The Company is required to prepay the new term loan prior to maturity upon the incurrence of certain new indebtedness or the issuance of capital stock, subject to limited exceptions.
Risks and Contingencies: The filing does not explicitly list new risks but notes that the credit facility is secured by the Company's assets and certain subsidiaries. The interest rate is variable based on leverage ratios.
Investor Verification Checklist
- Verify the actual drawdown amount and timing of the $700 million facility between July and September 2026.
- Confirm the Company's current Consolidated Net Leverage Ratio to determine the applicable interest margin.
- Review the specific terms of the "limited exceptions" regarding mandatory prepayment upon new debt issuance.
- Assess the impact of the new facility on the Company's overall debt maturity profile and liquidity position.